Systemic inflammatory markers as surrogate indicators of host immune response in predicting tumour aggressiveness in head and neck squamous cell carcinoma
Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology · 2026
DOI: 10.1016/j.oooo.2026.07.007 ↗Kurz gefasst
Fachartikel in der Zeitschrift Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology, 2026. Verfasst von Veeksha V Shetty und 6 weiteren Autor:innen. Beteiligte Einrichtung: Central Research Laboratory, Cellomics and Lipidomics, Nitte (Deemed to be University), KS Hegde Medical Academy (KSHEMA), Mangalore, India. Hauptthemen laut MEDLINE: Head and Neck Neoplasms, Biomarkers, Tumor, Carcinoma, Squamous Cell, Inflammation. Die Arbeit nennt 33 Literaturangaben.
Abstract (Originalsprache)
BACKGROUND: Inflammation is a hallmark of cancer and plays a critical role in tumour progression and prognosis. This study evaluates systemic blood count-based inflammatory markers in patients with head and neck squamous cell carcinoma (HNSCC) and their correlation with clinicopathological features and personal habits. METHODS: This prospective cross-sectional study included patients diagnosed with HNSCC whose clinicopathological data and haematological parameters were collected. The inflammatory ratios calculated included neutrophil-to-lymphocyte ratio (NLR), platelet-to-lymphocyte ratio, lymphocyte-to-monocyte ratio (LMR), monocyte-to-lymphocyte ratio (MLR) and systemic immune inflammation index (SII). RESULTS: Higher NLR was significantly associated with haemoglobin (Hb) levels in males (P = .045), tumour stage (P = .037) and nodal stage (P = .015), while elevated MLR correlated with nodal stage (P = .024). Lower LMR was associated with an advanced tumour stage (P = .028). Increased SII showed a significant association with gender (P = .04), Hb levels in males (P = .037) and tumour stage (P = .05). CONCLUSION: Elevated NLR, MLR and SII, along with reduced LMR, were significantly associated with advanced tumour and nodal stages in HNSCC. These easily measurable blood-based markers may serve as potential indicators of tumour aggressiveness and aid in early risk stratification of patients.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Central Research Laboratory, Cellomics and Lipidomics, Nitte (Deemed to be University), KS Hegde Medical Academy (KSHEMA), Mangalore, India.
- Central Research Laboratory, Cellomics and Lipidomics, Nitte (Deemed to be University), KS Hegde Medical Academy (KSHEMA), Mangalore, India. Electronic address: shilpajshetty@nitte.edu.in.
- Department of Surgical Oncology, Nitte (Deemed to be University), KS Hegde Medical Academy (KSHEMA), Mangalore, India.
- Department of Radiation Oncology, Nitte (Deemed to be University), KS Hegde Medical Academy (KSHEMA), Mangalore, India.
- Department of Otorhinolaryngology, Nitte (Deemed to be University), KS Hegde Medical Academy (KSHEMA), Mangalore, India.
- Faculty of Medicine, University of Miyazaki, Miyazaki, Japan.
Zitieren
APA
Shetty, V. V., Shetty, S. S., Rajendra, V. K., Sharan, K., Bhat, V., Madhyastha, H., & Kn, S. (2026). Systemic inflammatory markers as surrogate indicators of host immune response in predicting tumour aggressiveness in head and neck squamous cell carcinoma. Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology. https://doi.org/10.1016/j.oooo.2026.07.007
Vancouver
Shetty VV, Shetty SS, Rajendra VK, Sharan K, Bhat V, Madhyastha H, et al. Systemic inflammatory markers as surrogate indicators of host immune response in predicting tumour aggressiveness in head and neck squamous cell carcinoma. Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology. 2026. doi:10.1016/j.oooo.2026.07.007
BibTeX
@article{Shetty2026,
author = {Shetty, Veeksha V and Shetty, Shilpa S and Rajendra, Vinay Kumar and Sharan, Krishna and Bhat, Vadisha and Madhyastha, Harishkumar and Kn, Sandeepa},
title = {Systemic inflammatory markers as surrogate indicators of host immune response in predicting tumour aggressiveness in head and neck squamous cell carcinoma},
journal = {Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology},
year = {2026},
doi = {10.1016/j.oooo.2026.07.007}
}
EUVIMED